Latest Insider Transactions at New Amsterdam Pharma CO N.V. (NAMS)
This section provides a real-time view of insider transactions for New Amsterdam Pharma CO N.V. (NAMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NewAmsterdam Pharma Co N.V. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NewAmsterdam Pharma Co N.V.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,578
-12.47%
|
-
|
|
Jan 30
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,578
+19.08%
|
-
|
|
Jan 29
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
56,863
-56.38%
|
-
|
|
Jan 29
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,863
+36.05%
|
-
|
|
Jan 28
2025
|
Mayur Ian Somaiya Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,900
-14.98%
|
-
|
|
Jan 28
2025
|
Mayur Ian Somaiya Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,900
+21.98%
|
$134,100
$9.26 P/Share
|
|
Jan 28
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,385
-19.82%
|
-
|
|
Jan 28
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,385
+26.79%
|
-
|
|
Jan 27
2025
|
Mayur Ian Somaiya Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
46,983
-32.78%
|
-
|
|
Jan 27
2025
|
Mayur Ian Somaiya Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,983
+35.6%
|
$422,847
$9.26 P/Share
|
|
Jan 27
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
104,174
-44.68%
|
-
|
|
Jan 27
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104,174
+41.28%
|
-
|
|
Jan 07
2025
|
Mark C. Mc Kenna |
BUY
Grant, award, or other acquisition
|
Direct |
6,960
+50.0%
|
-
|
|
Jan 07
2025
|
John W Smither |
BUY
Grant, award, or other acquisition
|
Direct |
6,960
+50.0%
|
-
|
|
Jan 07
2025
|
William Lewis |
BUY
Grant, award, or other acquisition
|
Direct |
6,960
+50.0%
|
-
|
|
Jan 07
2025
|
Louis G Lange |
BUY
Grant, award, or other acquisition
|
Direct |
6,960
+50.0%
|
-
|
|
Jan 07
2025
|
Kamp Hilde Johanna Van Der |
BUY
Grant, award, or other acquisition
|
Direct |
6,960
+50.0%
|
-
|
|
Jan 07
2025
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+50.0%
|
-
|
|
Jan 07
2025
|
Michael H. Davidson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
123,529
+50.0%
|
-
|
|
Jan 07
2025
|
Louise Frederika Kooij Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jan 07
2025
|
Juliette Berangere Audet Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+48.1%
|
-
|
|
Jan 07
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+50.0%
|
-
|
|
Jan 07
2025
|
William A Jones Jr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,000
+50.0%
|
-
|
|
Jan 07
2025
|
Mayur Ian Somaiya Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+50.0%
|
-
|
|
Dec 30
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
29,846
-0.28%
|
$746,150
$25.54 P/Share
|
|
Dec 27
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
41,472
-0.39%
|
$1,036,800
$25.95 P/Share
|
|
Dec 26
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
33,438
-0.31%
|
$869,388
$26.01 P/Share
|
|
Dec 24
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
16,164
-0.15%
|
$404,100
$25.66 P/Share
|
|
Dec 23
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
25,132
-0.23%
|
$628,300
$25.49 P/Share
|
|
Dec 20
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
49,772
-0.23%
|
$1,244,300
$25.83 P/Share
|
|
Dec 19
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
56,506
-0.52%
|
$1,412,650
$25.45 P/Share
|
|
Dec 18
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
100,728
-0.46%
|
$2,618,928
$26.13 P/Share
|
|
Dec 17
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
114,384
-0.52%
|
$2,973,984
$26.03 P/Share
|
|
Dec 16
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
1,096
-0.01%
|
$27,400
$25.0 P/Share
|
|
Dec 13
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
25,751
-0.23%
|
$643,775
$25.01 P/Share
|
|
Dec 12
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
166,011
-0.73%
|
$4,150,275
$25.72 P/Share
|
|
Dec 11
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
154,038
-0.45%
|
$4,004,988
$26.26 P/Share
|
|
Dec 10
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
308,250
-1.31%
|
$7,706,250
$25.68 P/Share
|
|
Nov 18
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
33,273
-0.28%
|
$831,825
$25.08 P/Share
|
|
Nov 15
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
8,530
-0.07%
|
$213,250
$25.02 P/Share
|
|
Nov 14
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
9,832
-0.08%
|
$245,800
$25.01 P/Share
|
|
Nov 13
2024
|
Nap B.V. For Growth |
SELL
Open market or private sale
|
Indirect |
1,066
-0.01%
|
$26,650
$25.0 P/Share
|
|
Oct 01
2024
|
Louise Frederika Kooij Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
45,000
-100.0%
|
$675,000
$15.72 P/Share
|
|
Sep 27
2024
|
Louise Frederika Kooij Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+50.0%
|
-
|
|
Sep 26
2024
|
Juliette Berangere Audet Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,104
+50.0%
|
$16,560
$15.7 P/Share
|
|
Aug 20
2024
|
Michael H. Davidson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+2.33%
|
$80,000
$16.27 P/Share
|
|
Jun 20
2024
|
Michael H. Davidson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+2.38%
|
$85,000
$17.26 P/Share
|
|
Mar 26
2024
|
James N Topper |
BUY
Open market or private purchase
|
Indirect |
8,429
+0.28%
|
$177,009
$21.5 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
190,476
-100.0%
|
$3,999,996
$21.5 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
11,197
-5.55%
|
$246,334
$22.72 P/Share
|